Second Sight Medical Products is a medical devices business based in the US. Second Sight Medical Products shares (EYES) are listed on the NASDAQ and all prices are listed in US Dollars. Second Sight Medical Products employs 15 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Second Sight Medical Products
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – EYES – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Active traders

What's in this guide?
Second Sight Medical Products stock price (NASDAQ: EYES)
Use our graph to track the performance of EYES stocks over time.Second Sight Medical Products shares at a glance
Latest market close | $2.22 |
---|---|
52-week range | $1.14 - $5.28 |
50-day moving average | $1.90 |
200-day moving average | $1.97 |
Wall St. target price | $2.50 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.23 |
Buy Second Sight Medical Products shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Second Sight Medical Products stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Second Sight Medical Products price performance over time
Historical closes compared with the close of $2.22 from 2022-07-05
1 week (2022-06-30) | 9.36% |
---|---|
1 month (2022-06-06) | -10.48% |
3 months (2022-04-07) | 58.57% |
6 months (2022-01-03) | N/A |
1 year (2021-07-07) | -46.63% |
---|---|
2 years (2020-07-07) | 145.30% |
3 years (2019-07-05) | 182.16% |
5 years (2017-07-07) | 83.47% |
Second Sight Medical Products financials
Revenue TTM | $497,000 |
---|---|
Gross profit TTM | $130,000 |
Return on assets TTM | -10.74% |
Return on equity TTM | -19.02% |
Profit margin | 0% |
Book value | $1.68 |
Market capitalisation | $80 million |
TTM: trailing 12 months
Second Sight Medical Products share dividends
We're not expecting Second Sight Medical Products to pay a dividend over the next 12 months.
Have Second Sight Medical Products's shares ever split?
Second Sight Medical Products's shares were split on a 1:8 basis on 5 January 2020. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Second Sight Medical Products shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Second Sight Medical Products shares which in turn could have impacted Second Sight Medical Products's share price.
Second Sight Medical Products share price volatility
Over the last 12 months, Second Sight Medical Products's shares have ranged in value from as little as $1.14 up to $5.28. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Second Sight Medical Products's is 2.8153. This would suggest that Second Sight Medical Products's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Second Sight Medical Products overview
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California. .
Frequently asked questions
What percentage of Second Sight Medical Products is owned by insiders or institutions?Currently 28.611% of Second Sight Medical Products shares are held by insiders and 6.965% by institutions. How many people work for Second Sight Medical Products?
Latest data suggests 15 work at Second Sight Medical Products. When does the fiscal year end for Second Sight Medical Products?
Second Sight Medical Products's fiscal year ends in December. Where is Second Sight Medical Products based?
Second Sight Medical Products's address is: 13170 Telfair Avenue, Sylmar, CA, United States, 91342 What is Second Sight Medical Products's ISIN number?
Second Sight Medical Products's international securities identification number is: US81362J2096 What is Second Sight Medical Products's CUSIP number?
Second Sight Medical Products's Committee on Uniform Securities Identification Procedures number is: 81362J100
More guides on Finder
-
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
-
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
-
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert